Schizophrenia
-
A connection to schizophrenia
The insula, a small region of the brain involved in diverse brain functions had widespread dysconnectivity in schizophrenia, Vanderbilt researchers found. Read MoreJune 23, 2020
-
Relational memory in early psychosis
Studies of relational memory function may reveal novel mechanisms for therapeutic intervention for patients in the early stages of psychosis. Read MoreSeptember 10, 2019
-
Working memory in psychotic disorders
Functional MRI studies have revealed that targeting activation of certain brain regions may improve working memory and cognition in psychotic disorders. Read MoreJuly 11, 2019
-
Early detection of schizophrenia
Inhibited temperament—a tendency to respond to novelty with wariness, fear or caution—may be a risk factor for schizophrenia that could be targeted for preventative interventions. Read MoreJune 24, 2019
-
Team finds how error and reward signals are organized within cerebral cortex
Psychiatrists diagnose people with schizophrenia, ADHD, bipolar disorder and other mental illnesses by spending time with them, looking for the particular behavior symptoms of each. What follows can be a hit-or-miss series of medications and dosages until disruptive behaviors go away. By deciphering the circuitry of the medial frontal cortex… Read MoreJanuary 14, 2019
-
People with schizophrenia experience emotion differently from others, ‘body maps’ show
Vanderbilt University researchers are working to understand how people with schizophrenia experience emotion through their bodies. Read MoreDecember 21, 2018
-
Shared genetics may shape treatment options for certain brain disorders
Symptoms of schizophrenia and bipolar disorder, including psychosis, depression and manic behavior, have both shared and distinguishing genetic factors, an international consortium led by researchers from Vanderbilt University and Virginia Commonwealth University is reporting. Read MoreJune 14, 2018
-
Brain connections in schizophrenia
Brain imaging studies have implicated the connection between two brain regions in the pathophysiology of schizophrenia. Read MoreMarch 9, 2018
-
Vanderbilt signs licensing, research agreements to develop new approach to schizophrenia treatment
Under the terms of the licensing agreement, Lundbeck has exclusively licensed rights to compounds developed at Vanderbilt that act on a receptor in the brain that has been implicated in schizophrenia. Read MoreJanuary 8, 2018
-
Investigational new drug for Alzheimer’s scheduled for first study in humans
Vanderbilt University scientists have received notification from the U.S. Food and Drug Administration that testing in humans may proceed for an investigational new drug for Alzheimer's disease after more than 10 years of research by scientists at Vanderbilt University and Vanderbilt University Medical Center. Read MoreDecember 27, 2016